Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mipomersen as Add-on Therapy in High Risk Hypercholesterolemia
NCT00770146Phase 3Completed
- Sponsor
- Kastle Therapeutics LLC
- Start
- Nov 2008
- Primary completion
- May 2010
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 3 trial of mipomersen in hypercholesterolemia, sponsored by Kastle Therapeutics LLC. Started Nov 2008; status: completed.
02
Drugs
mipomersen
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00770146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00770146.